Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. www.ilb.de › media › dokumenteSphingoTec erweitert Management-Team und ernennt neuen CFO - ILB

    Juni 2021 - Das Diagnostikunternehmen SphingoTec GmbH ("SphingoTec") gibt die Ernennung von Dr. Angelo Moesslang zum neuen Chief Financial Officer (CFO) und Geschäftsführer bekannt. SphingoTec entwickelt und vermarktet innovative in-vitro-diagnostische Lösungen für neuartige Biomarker, welche die personalisierte Medizin in der ...

  2. sphingotec.com › resource-center › scientific-publicationsScientific Publications - sphingotec.com

    SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. Browse our scientific publications to learn more about how our biomarkers can impact patient care. You can use filters to narrow your search results by Year, Biomarker and ...

  3. www.trillium.de › zeitschriften › trillium-diagnostiksphingotec - trillium.de

    Mittels sphingotest ® penKid lässt sich aktuell die Funktionsfähigkeit der Nieren ermitteln, während sich der Kreatinin-Spiegel erst nach einer erfolgten Nierenschädigung mit 1–2 Tagen Verzögerung ändert. Mithilfe des penKid Immuno­assays lässt sich indirekt die Enkephalin-Konzentration im Blutplasma bestimmen [3].

  4. sphingotec.com › news › detailEndothelial function biomarker bioactive Adrenomedullin (bio-ADM...

    1. Aug. 2022 · New findings support the clinical value of the biomarker bio-ADM for triaging sepsis patients in ED, exceeding the prognostic performance of routine biomarkers. So far, the predictive potential of the innovative biomarker has been confirmed and used primarily in ICU. A new study, recently published, confirms its applicability in ED.

  5. european-biotechnology.com › up-to-date › latest-newsSphingotec raises €20m in growth equity financing

    10. Juli 2018 · 07.10.2018 by TG. Diagnostics company sphingotec GmbH successfully closed a €20m growth equity financing round led by international specialist investors HBM Healthcare Investments, HBM BioCapital II LP (HBM) and Wellington Partners. Sphingotec announced it will primarily use the proceeds to roll out the fully automated IB 10 point-of-care ...

  6. sphingotec.com › news › detailsphingotec raises €20 million from HBM and Wellington Partners

    8. Okt. 2018 · HENNIGSDORF, Germany - October 8, 2018 - German diagnostics company SphingoTec GmbH has closed a €20m growth equity financing round led by international healthcare specialist investors HBM and Wellington Partners. Sphingotec will primarily use the proceeds to roll out the fully automated IB 10 point-of-care (POC) platform for testing of a ...

  7. sphingotec.com › orderOrder - sphingotec.com

    order [at]sphingotec.com. Sphingotest ® penKid ® and sphingotest ® bio-ADM ® are CE IVD marked and are intended for the in vitro quantitative determination of Proenkephalin A 119-159 (penKid) and bioactive Adrenomedullin 1-52 (bio-ADM) in human EDTA plasma. The assays are designed for professional use only and may be used in central ...

  1. Verwandte Suchbegriffe zu sphingotech twitter

    belano medical
    4teen4
    pentracor
    hbm healthcare investments
    penninkhof
    codon ariva
    adrenomed twitter
    adrenomed
  2. Nutzer haben außerdem gesucht nach